15-Deoxy-Δ^12,14-prostaglandin J₂ stabilizes hypoxia inducible factor-1α through induction of heme oxygenase-1 and direct modification ofprolyl-4-hydroxylase 2

References

• McPherson K, Steel CM, Dixon JM. ABC of breast diseases. Breast cancer – epidemiology, risk factors, and genetics. BMG 2000;321:624–628.
   PubMed Web of Science ®Google Scholar
• Dannenberg AJ, Howe LR. The role of COX-2 in breast and cervical cancer. Prog Exp Tumor Res 2003;37:90–106.
   PubMed Web of Science ®Google Scholar
• Bluff JE, Menakuru SR, Cross SS, Higham SE, Balasubramanian SP, Brown NJ, et al. Angiogenesis is associated with the onset of hyperplasia in human ductal breast disease. Br J Cancer 2009;101:666–672.
   PubMed Web of Science ®Google Scholar
• Costa C, Soares R, Reis-Filho JS, Leitão D, Amendoeira I, Schmitt FC. Cyclo-oxygenase 2 expression is associated with angiogenesis and lymph node metastasis in human breast cancer. J Clin Pathol 2002;55:429–434.
   PubMed Web of Science ®Google Scholar
• Bos R, van Diest PJ, de Jong JS, van der Groep P, van der Valk P, van der Wall E. Hypoxia-inducible factor-1alpha is associated with angiogenesis, and expression of bFGF, PDGF-BB, and EGFR in invasive breast cancer. Histopathology 2005;46:31–36.
   PubMed Web of Science ®Google Scholar
• Chinery R, Coffey RJ, Graves-Deal R, Kirkland SC, Sanchez SC, Zackert WE, et al. Prostaglandin J2 and 15-deoxy-Δ12,14-prostaglandin J2 induce proliferation of cyclooxygenase-depleted colorectal cancer cells. Cancer Res 1999;59:2739–2746.
   PubMed Web of Science ®Google Scholar
• Clay CE, Namen AM, Atsumi G, Willingham MC, High KP, Kute TE, et al. Influence of J series prostaglandins on apoptosis and tumorigenesis of breast cancer cells. Carcinogenesis 1999;20:1905–1911.
   PubMed Web of Science ®Google Scholar
• Kim D-H, Kim J-H, Kim E-H, Na H-K, Cha Y-N, Chung JH, Surh Y-J. 15-Deoxy-Δ12,14-prostaglandin J2 upregulates the expression of heme oxygenase-1 and subsequently matrix metalloproteinase-1 in human breast cancer cells: possible roles of iron and ROS. Carcinogenesis 2009;30:645–654.
   PubMed Web of Science ®Google Scholar
• Kim E-H, Na H-K, Surh Y-J. Upregulation of VEGF by 15-deoxy-Δ12,14-prostaglandin J2 via heme oxygenase-1 and ERK1/2 signaling in MCF-7 cells. Ann NY Acad Sci 2006;1090:375–384.
   PubMed Web of Science ®Google Scholar
• Semenza GL. Targeting HIF-1 for cancer therapy. Nat Rev Cancer 2003;3:721–732.
   PubMed Web of Science ®Google Scholar
• Jaakkola P, Mole DR, Tian YM, Wilson MI, Gielbert J, Gaskell SJ, et al. Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science 2001;292:468–472.
   PubMed Web of Science ®Google Scholar
• Wenger RH, Stiehl DP, Camenisch G. Integration of oxygen signaling at the consensus HRE. Sci STKE 2005;2005:re12.
   PubMedGoogle Scholar
• Epstein AC, Gleadle JM, McNeill LA, Hewitson KS, O’Rourke J, Mole DR, et al. C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 2001;107:43–54.
   PubMed Web of Science ®Google Scholar
• Hirsilä M, Koivunen P, Günzler V, Kivirikko KI, Myllyharju J. Characterization of the human prolyl 4-hydroxylases that modify the hypoxia-inducible factor. J Biol Chem 2003;278:30772–30780.
   PubMed Web of Science ®Google Scholar
• Berra E, Benizri E, Ginouvès A, Volmat V, Roux D, Pouyssegur J. HIF prolyl-hydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1α in normoxia. EMBO J 2003;22:4082–4090.
   PubMed Web of Science ®Google Scholar
• Ivan M, Kondo K, Yang H, Kim W, Valiando J, Ohh M, et al. HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science 2001;292:464–468.
   PubMed Web of Science ®Google Scholar
• Dulak J, Deshane J, Jozkowicz A, Agarwal A. Heme oxygenase-1 and carbon monoxide in vascular pathobiology: focus on angiogenesis. Circulation 2008;117:231–241.
   PubMed Web of Science ®Google Scholar
• Song N-Y, Kim D-H, Kim E-H, Na H-K, Surh Y-J. 15-Deoxy-Δ12,14-prostaglandin J2 induces upregulation of multidrug resistance-associated protein 1 via Nrf2 activation in human breast cancer cells. Ann NY Acad Sci 2009;1171:210–216.
   PubMed Web of Science ®Google Scholar
• Miralem T, Hu Z, Torno MD, Lelli KM, Maines MD. Small interference RNA-mediated gene silencing of human biliverdin reductase, but not that of heme oxygenase-1, attenuates arsenite-mediated induction of the oxygenase and increases apoptosis in 293A kidney cells. J Biol Chem 2005;280:17084–17092.
   PubMed Web of Science ®Google Scholar
• Wizard PP. Schrödinger Suite Epik, version 2.0 (2009) Schrödinger, LLC, New York, NY.
   Google Scholar
• Zhuang H, Kim Y-S, Namiranian K, Doré S. Prostaglandins of J series control heme oxygenase expression: potential significance in modulating neuroinflammation. Ann NY Acad Sci 2003;993:208–216.
   PubMed Web of Science ®Google Scholar
• Chin BY, Jiang G, Wegiel B, Wang HJ, Macdonald T, Zhang XC, et al. Hypoxia-inducible factor 1alpha stabilization by carbon monoxide results in cytoprotective preconditioning. Proc Natl Acad Sci USA 2007;104:5109–5114.
   PubMed Web of Science ®Google Scholar
• Converso DP, Taillé C, Carreras MC, Jaitovich A, Poderoso JJ, Boczkowski J. HO-1 is located in liver mitochondria and modulates mitochondrial heme content and metabolism. FASEB J 2006;20:1236–1238.
   PubMed Web of Science ®Google Scholar
• Atamna H, Liu J, Ames BN. Heme deficiency selectively interrupts assembly of mitochondrial complex IV in human fibroblasts: relevance to aging. J Biol Chem 2001;276:48410–48416.
   PubMed Web of Science ®Google Scholar
• Park J-H, Kim T-Y, Jong H-S, Kim TY, Chun Y-S, Park J-W, et al. Gastric epithelial reactive oxygen species prevent normoxic degradation of hypoxia-inducible factor-1α in gastric cancer cells. Clin Cancer Res 2003;9:433–440.
   PubMed Web of Science ®Google Scholar
• Gao P, Zhang H, Dinavahi R, Li F, Xiang Y, Raman V, et al. HIF-dependent antitumorigenic effect of antioxidants in vivo. Cancer Cell 2007;12:230–238.
   PubMed Web of Science ®Google Scholar
• Yu F, White SB, Zhao Q, Lee FS. HIF-1α binding to VHL is regulated by stimulus-sensitive proline hydroxylation. Proc Natl Acad Sci USA 2001;98:9630–9635.
   PubMed Web of Science ®Google Scholar
• Oh JY, Giles N, Landar A, Darley-Usmar V. Accumulation of 15-deoxy-Δ12,14-prostaglandin J2 adduct formation with Keap1 over time: effects on potency for intracellular antioxidant defence induction. Biochem J 2008;411:297–306.
   PubMed Web of Science ®Google Scholar
• Sánchez-Gómez FJ, Cernuda-Morollón E, Stamatakis K, Pérez-Sala D. Protein thiol modification by 15-deoxy-Δ12,14-prostaglandin J2 addition in mesangial cells: role in the inhibition of pro-inflammatory genes. Mol Pharmacol 2004;66:1349–1358.
   PubMed Web of Science ®Google Scholar
• Oliva JL, Pérez-Sala D, Castrillo A, Martínez N, Cañada FJ, Boscá L, Rojas JM. The cyclopentenone 15-deoxy-Δ12,14-prostaglandin J2 binds to and activates H-Ras. Proc Natl Acad Sci USA 2003;100:4772–4777.
   PubMed Web of Science ®Google Scholar
• Cernuda-Morollón E, Pineda-Molina E, Cañada FJ, Pérez-Sala D. 15-Deoxy-Δ12,14-prostaglandin J2 inhibition of NF-κB-DNA binding through covalent modification of the p50 subunit. J Biol Chem 2001;276:35530–35536.
   PubMed Web of Science ®Google Scholar
• Pérez-Sala D, Cernuda-Morollón E, Cañada FJ. Molecular basis for the direct inhibition of AP-1 DNA binding by 15-deoxy-Δ12,14-prostaglandin J2. J Biol Chem 2003;278:51251–51260.
   PubMed Web of Science ®Google Scholar
• Chowdhury R, McDonough MA, Mecinović J, Loenarz C, Flashman E, Hewitson KS, et al. Structural basis for binding of hypoxia-inducible factor to the oxygen-sensing prolyl hydroxylases. Structure 2009;17:981–989.
   PubMed Web of Science ®Google Scholar
• Mecinović J, Chowdhury R, Flashman E, Schofield CJ. Use of mass spectrometry to probe the nucleophilicity of cysteinyl residues of prolyl hydroxylase domain 2. Anal Biochem 2009;393:215–221.
   PubMed Web of Science ®Google Scholar
• Howe LR. Inflammation and breast cancer. Cyclooxygenase/prostaglandin signaling and breast cancer. Breast Cancer Res 2007;9:210.
   PubMed Web of Science ®Google Scholar
• Tiano HF, Loftin CD, Akunda J, Lee CA, Spalding J, Sessoms A, et al. Deficiency of either cyclooxygenase (COX)-1 or COX-2 alters epidermal differentiation and reduces mouse skin tumorigenesis. Cancer Res 2002;62:3395–3401.
   PubMed Web of Science ®Google Scholar
• Müller-Decker K, Neufang G, Berger I, Neumann M, Marks F, Fürstenberger G. Transgenic cyclooxygenase-2 overexpression sensitizes mouse skin for carcinogenesis. Proc Natl Acad Sci USA 2002;99:12483–12488.
   PubMed Web of Science ®Google Scholar
• Fischer SM. Is cyclooxygenase-2 important in skin carcinogenesis? J Environ Pathol Toxicol Oncol 2002;21:183–191.
   PubMedGoogle Scholar
• Tsujii M, Kawano S, Tsuji S, Sawaoka H, Hori M, DuBois RN. Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell 1998;93:705–716.
   PubMed Web of Science ®Google Scholar
• Pelletier JP, Mineau F, Martel-Pelletier J. 15d-PGJ2 is acting as a “dual agent” on the regulation of COX-2 expression in human osteoarthritic chondrocytes. Osteoarthritis Cartilage 2002;11:845–848.
   Google Scholar
• Kim E-H, Na H-K, Kim D-H, Park S-A, Kim H-N, Song N-Y, Surh Y-J. 15-Deoxy-Δ12,14-prostaglandin J2 induces COX-2 expression through Akt-driven AP-1 activation in human breast cancer cells: a potential role of ROS. Carcinogenesis 2008;29:688–695.
   PubMed Web of Science ®Google Scholar
• Vichai V, Suyarnsesthakorn C, Pittayakhajonwut D, Sriklung K, Kirtikara K. Positive feedback regulation of COX-2 expression by prostaglandin metabolites. Inflamm Res 2005;54:163–172.
   PubMed Web of Science ®Google Scholar
• Kim E-H, Surh Y-J. The role of 15-deoxy-Δ12,14-prostaglandin J2, an endogenous ligand of peroxisome proliferator-activated receptor gamma, in tumor angiogenesis. Biochem Pharmacol 2008;76:1544–1553.
   PubMed Web of Science ®Google Scholar
• Chandel NS, McClintock DS, Feliciano CE, Wood TM, Melendez JA, Rodriguez AM, Schumacker PT. Reactive oxygen species generated at mitochondrial complex III stabilize hydpoxia-inducible factor-1α during hypoxia: a mechanism of O2 sensing. J Biol Chem 2000;275:25130–25138.
   PubMed Web of Science ®Google Scholar
• Semenza GL. HIF-1 and mechanisms of hypoxia sensing. Curr Opin Cell Biol 2001;13:167–171.
   PubMed Web of Science ®Google Scholar
• Lu H, Dalgard CL, Mohyeldin A, McFate T, Tait AS, Verma A. Reversible inactivation of HIF-1 prolyl hydroxylases allows cell metabolism to control basal HIF-1. J Biol Chem 2005;280:41928–41939.
   PubMed Web of Science ®Google Scholar
• Alcaraz MJ, Fernández P, Guillén MI. Anti-inflammatory actions of the heme oxygenase-1 pathway. Curr Pharm Des 2003;9:2541–2551.
   PubMed Web of Science ®Google Scholar
• Dulak J, Łoboda A, Zagórska A, Jozkowicz A. Complex role of heme oxygenase-1 in angiogenesis. Antioxid Redox Signal 2004;6:858–866.
   PubMed Web of Science ®Google Scholar
• Sunamura M, Duda DG, Ghattas MH, Lozonschi L, Motoi F, Yamauchi J-I, et al. Heme oxygenase-1 accelerates tumor angiogenesis of human pancreatic cancer. Angiogenesis 2003;6:15–24.
   PubMedGoogle Scholar
• Bussolati B, Ahmed A, Pemberton H, Landis RC, Di Carlo F, Haskard DO, Mason JC. Bifunctional role for VEGF-induced heme oxygenase-1 in vivo: induction of angiogenesis and inhibition of leukocytic infiltration. Blood 2004;103:761–766.
   PubMed Web of Science ®Google Scholar
• Bussolati B, Mason JC. Dual role of VEGF-induced heme-oxygenase-1 in angiogenesis. Antioxid Redox Signal 2006;8:1153–1163.
   PubMed Web of Science ®Google Scholar
• Pouyssegur J, Dayan F, Mazure NM. Hypoxia signalling in cancer and approaches to enforce tumour regression. Nature 2006;441:437–443.
   PubMed Web of Science ®Google Scholar
• Lee PJ, Jiang BH, Chin BY, Iyer NV, Alam J, Semenza GL, Choi AM. Hypoxia-inducible factor-1 mediates transcriptional activation of the heme oxygenase-1 gene in response to hypoxia. J Biol Chem 1997;272:5375–5381.
   PubMed Web of Science ®Google Scholar
• Weidemann A, Johnson RS. Biology of HIF-1alpha. Cell Death Differ 2008;15:621–627.
   PubMed Web of Science ®Google Scholar
• Barth S, Nesper J, Hasgall PA, Wirthner R, Nytko KJ, Edlich F, et al. The peptidyl prolyl cis/trans isomerase FKBP38 determines hypoxia-inducible transcription factor prolyl-4-hydroxylase PHD2 protein stability. Mol Cell Biol 2007;27:3758–3768.
   PubMed Web of Science ®Google Scholar
• Barth S, Edlich F, Berchner-Pfannschmidt U, Gneuss S, Jahreis G, Hasgall PA, et al. Hypoxia-inducible factor prolyl-4-hydroxylase PHD2 protein abundance depends on integral membrane anchoring of FKBP38. J Biol Chem 2009;284:23046–23058.
   PubMed Web of Science ®Google Scholar
• Selak MA, Armour SM, MacKenzie ED, Boulahbel H, Watson DG, Mansfield KD, et al. Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase. Cancer Cell 2005;7:77–85.
   PubMed Web of Science ®Google Scholar
• Takeda K, Fong G-H. Prolyl hydroxylase domain 2 protein suppresses hypoxia-induced endothelial cell proliferation. Hypertension 2007;49:178–184.
   PubMed Web of Science ®Google Scholar
• Lee K, Lynd JD, O’Reilly S, Kiupel M, McCormick JJ, LaPres JJ. The biphasic role of the hypoxia-inducible factor prolyl-4-hydroxylase, PHD2, in modulating tumor-forming potential. Mol Cancer Res 2008;6:829–842.
   PubMed Web of Science ®Google Scholar
• Ivan M, Kaelin WG. The von Hippel-Lindau tumor suppressor protein. Curr Opin Genet Dev 2001;11:27–34.
   PubMed Web of Science ®Google Scholar
• Kim WY, Kaelin WG. Role of VHL gene mutation in human cancer. J Clin Oncol 2004;22:4991–5004.
   PubMed Web of Science ®Google Scholar
• Siemeister G, Weindel K, Mohrs K, Barleon B, Martiny-Baron G, Marmé D. Reversion of deregulated expression of vascular endothelial growth factor in human renal carcinoma cells by von Hippel-Lindau tumor suppressor protein. Cancer Res 1996;56:2299–2301.
   PubMed Web of Science ®Google Scholar
• Gnarra JR, Zhou S, Merrill MJ, Wagner JR, Krumm A, Papavassiliou E, et al. Post-transcriptional regulation of vascular endothelial growth factor mRNA by the product of the VHL tumor suppressor gene. Proc Natl Acad Sci USA 1996;93:10589–10594.
   PubMed Web of Science ®Google Scholar
• Straus DS, Pascual G, Li M, Welch JS, Ricote M, Hsiang CH, et al. 15-Deoxy-Δ12,14-prostaglandin J2 inhibits multiple steps in the NF-κB signaling pathway. Proc Natl Acad Sci USA 2000;97:4844–4849.
   PubMed Web of Science ®Google Scholar
• Shibata T, Yamada T, Kondo M, Tanahashi N, Tanaka K, Nakamura H, et al. An endogenous electrophile that modulates the regulatory mechanism of protein turnover: inhibitory effects of 15-deoxy-Δ12,14-prostaglandin J2 on proteasome. Biochemistry 2003;42:13960–13968.
   PubMed Web of Science ®Google Scholar
• Kim DH, Kim E-H, Na H-K, Sun Y, Surh Y-J. 15-Deoxy-Δ12,14-prostaglandin J2 stabilizes, but functionally inactivates p53 by binding to the cysteine 277 residue. Oncogene 2010;29:2560–2576.
   PubMed Web of Science ®Google Scholar
• McDonough MA, Li V, Flashman E, Chowdhury R, Mohr C, Liénard BMR, et al. Cellular oxygen sensing: Crystal structure of hypoxia-inducible factor prolyl hydroxylase (PHD2). Proc Natl Acad Sci USA 2006;103:9814–9819.
   PubMed Web of Science ®Google Scholar
• Olmos G, Conde I, Arenas I, Del Peso L, Castellanos C, Landazuri MO, Lucio-Cazana J. Accumulation of hypoxia-inducible factor-1α through a novel electrophilic, thiol antioxidant-sensitive mechanism. Cell Signal 2007;19:2098–2105.
   PubMed Web of Science ®Google Scholar
• Olmos G, Arenas MI, Bienes R, Calzada MJ, Aragonés J, Garcia-Bermejo ML, et al. 15-Deoxy-Δ12,14-prostaglandin-J2 reveals a new pVHL-independent, lysosomal-dependent mechanism of HIF-1α degradation. Cell Mol Life Sci 2009;66:2167–2180.
   PubMed Web of Science ®Google Scholar
• Jozkowicz A, Nigisch A, Wegrzyn J, Weigel G, Huk I, Dulak J. Opposite effects of prostaglandin-J2 on VEGF in normoxia and hypoxia: role of HIF-1. Biochem Biophys Res Commun 2004;314:31–38.
   PubMed Web of Science ®Google Scholar